The Abu Dhabi Stem Cells Centre (ADSCC) has unveiled a pioneering treatment option for Multiple Sclerosis (MS) through the THERAKOS CELLEX platform for photopheresis. This initiative is part of a clinical trial sanctioned by the Department of Health – Abu Dhabi, offering new hope to those grappling with this complex neurological condition and aiming to enhance their daily living.
MS is a chronic condition wherein the immune system targets the body's nervous system, leading to issues with movement, balance, and communication. Existing therapies frequently become ineffective over time, necessitating the investigation of new treatment avenues. The extracorporeal photopheresis (ECP) approach utilized by ADSCC provides hope for patients who have limited remaining options.
Photopheresis, previously employed for conditions like graft-versus-host disease, involves extracting a patient's white blood cells, treating them with light externally, and reinfusing them. This process is designed to recalibrate the immune system, potentially mitigating the impacts of MS, such as walking difficulties and speech impairments.
As part of the PHOMS clinical study sanctioned by the Department of Health – Abu Dhabi, ADSCC focuses on individuals with Secondary Progressive MS and Relapsing-Remitting MS. Many participants have reported notable improvements in mobility and speech, indicating results unachievable through conventional therapies. These encouraging outcomes suggest photopheresis could revolutionize treatment for MS patients.
Prof. Yendry Ventura, the CEO of ADSCC, emphasized the collaborative efforts among Abu Dhabi's healthcare stakeholders, including the DOH and the MS Society, as vital to this study’s achievements. He mentioned that forthcoming results may pave the way for this groundbreaking MS treatment to be recognized globally, further establishing the UAE as a frontrunner in cell and gene therapy.
Sandra Thompson, Co-CEO of Therakos LLC, lauded the commitment and skill showcased by ADSCC, stating that this partnership is poised to foster significant advancements for the MS community in the UAE. This collaboration aims to merge innovative scientific approaches with patient-centered research, ultimately enhancing treatment outcomes and generating hope for those living with MS.
This advanced treatment represents a substantial leap forward for the global MS community. Through scientific innovation and dedicated patient care, the UAE is charting new paths for individuals confronting this challenging condition. With ongoing research and teamwork, photopheresis might soon become a standard therapeutic option for MS, providing relief and improved living conditions for patients everywhere.
An UAE flight delivered 100 tonnes of food to Egypt's Al Arish, aiding Gaza as part of Operation Chi
Vancouver designer John Fluevog creates a special shoe to honor a friend who donated her kidney rai
A chartered plane crashed in Jashpur, claiming the lives of both the pilot and co-pilot. Rescue effo
Survivors of Canada’s residential schools urge action as abuse testimonies risk destruction by 2027
